Sinead Knight

Sinead Knight is a highly experienced Senior Principal Scientist currently leading efforts at Sygnature Discovery since April 2021, focusing on drug discovery projects in collaboration with SMEs and biotech companies. Prior to this role, Sinead served as an Associate Principal Scientist in Functional Genomics at AstraZeneca from August 2012 to April 2021, where expertise in cutting-edge technology and informatics was applied to discover and translate biology and novel targets across various therapeutic areas, including cardiovascular and oncology. Additional experience includes positions as a Senior Scientist at Pro-Cure Therapeutics and as a Scientist at Opsona Therapeutics and EIRX Therapeutics, which contribute to a comprehensive background in drug discovery from early hit identification to candidate selection.